BioSpace News Archive

Carmel-based PathogenX Inc., which develops, manufactures and distributes proprietary technology designed to dramatically simplify the process of medical waste disposal, today announced it is approved for full national sales throughout Canada for its unique, double-batch, on-site sterilization device, the PX2.

ROSALIND®, a software leader in extracting meaningful insights from diverse pools of life science data, today announced the launch of a web-based platform for monitoring the emergence of SARS-CoV-2 variants and evaluating the effects on the performance of diagnostic tests.

Report provides a complete analysis on leading United States pharmaceutical companies’ COVID-19 approaches for Field-Based Personnel.

Physician Retraining and Reentry, Inc., a San Diego-based program that educates and trains physicians to return to practice as primary care doctors, announced today it has entered a growth investment and partnership with Teal Ventures, a leading digital healthcare venture capital firm.

Diversified Medical Healthcare (DMH), a holding company with four subsidiary healthcare companies, Premier Medical Laboratory Services (PMLS), CPT Medical, OnGen, and Vessel Medical, has provided leading-edge solutions to combat COVID-19 nationally, addressing supply chain gaps and infrastructure restrictions caused by the virus.

Data presented at ENDO 2021 demonstrate clinically relevant weight loss, without weight regain, in people treated with semaglutide 2.4 mg vs placebo in combination with lifestyle intervention

Aber Instruments (Aber), a world-leading manufacturer of on-line biomass monitoring technology, is delighted to announce its new Futura neotf single-use biomass sensor is available.

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the fiscal year ended December 31, 2020

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced its financial results for the fourth quarter and full year 2020 and provided an overview of recent business highlights.

Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today reported recent business progress and fourth quarter and full year 2020 financial results. “